RapidAI's platform leverages artificial intelligence to support clinical decision-making in neurovascular emergencies, such as strokes and aneurysms. It integrates advanced imaging analytics with streamlined workflows, allowing physicians to assess and act on critical patient data rapidly. This results in improved patient outcomes by reducing time to treatment and improving diagnostic accuracy. RapidAI's tools are FDA-cleared and designed to optimize the clinical processes in emergency settings.

RSIP Vision provides cutting-edge AI software tailored for medical imaging applications. With a focus on fields like radiology, neurology, and orthopedics, their solutions automate and enhance the interpretation of medical images. The software enables healthcare professionals to identify critical abnormalities with precision, allowing for faster diagnosis and treatment planning. By leveraging machine learning and computer vision technologies, RSIP Vision alleviates the burden of manual analysis, optimizing efficiency and improving patient outcomes.

RapidAI offers a suite of AI-powered solutionsfor neurovascular and vascular imaging. It significantly reduces the time to diagnosis and treatment, providing high-quality advanced imaging views. Their platform supports comprehensive cerebral aneurysm management, stroke care, and more. RapidAI stands as a clinically validated leader in the market, designed to fit hospitals of all sizes, empowering healthcare professionals with reliable and efficient tools to improve patient care.

CT Read is an advanced AI-based tool designed to interpret medical images such as X-rays, CT scans, MRIs, and ultrasounds. It provides quick and accurate evaluations, helping users understand the details of their scans. The tool supports a variety of file formats including DICOM, JPG, and PNG, making it accessible and easy to use. Comprehensive reports generated by CT Read offer detailed findings, key recommendations, and easy-to-understand summaries for both medical professionals and patients.